Science Explorer Back to mapMap
Discussion
Institution · National Centre for Infectious Diseases

Most cited papers from National Centre for Infectious Diseases

National Centre for Infectious Diseases

What are the most cited papers from National Centre for Infectious Diseases?

The most cited paper from National Centre for Infectious Diseases is "Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient" (Sean Wei Xiang Ong, Yian Kim Tan, Po Ying Chia et al., 2020), with 2,259 citations. Next come "Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore" (2,225) and "SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls" (2,165).

Showing 50 of 59 papers. Every paper with more than 221 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient Sean Wei Xiang Ong, Yian Kim Tan, Po Ying Chia et al. · JAMA Open access 4 Mar 2020 2,259
2 Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore Barnaby Edward Young et al. · JAMA Open access 3 Mar 2020 2,225
3 SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls Nina Le Bert, Anthony Tanoto Tan, Kamini Kunasegaran et al. · Nature Open access 15 Jul 2020 2,165
4 A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction Chee Wah Tan, Wan Ni Chia, Xijian Qin et al. · Nature Biotechnology Open access 23 Jul 2020 1,377
5 GISAID’s Role in Pandemic Response Shruti Khare, GISAID Global Data Science Initiative (GISAID), Munich, Germany, Céline Gurry et al. · China CDC Weekly Open access 2021 1,189
6 A living WHO guideline on drugs for covid-19 (2020-2023) Arnav Agarwal et al. · BMJ Open access 4 Sep 2020 1,096
7 Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients Po Ying Chia et al. · Nature Communications Open access 29 May 2020 953
8 Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients Anthony Tanoto Tan, Martin Linster, Chee Wah Tan et al. · Cell Reports Open access 21 Jan 2021 816
9 Hematologic parameters in patients with COVID‐19 infection Bingwen Eugene Fan, Vanessa Cui Lian Chong, Stephrene Seok Wei Chan et al. · American Journal of Hematology 4 Mar 2020 796
10 Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures Rachael Pung et al. · The Lancet Open access Mar 2020 714
11 Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review Junxiong Pang, Min Xian Wang, Ian Yi Han Ang et al. · Journal of Clinical Medicine ReviewOpen access 26 Feb 2020 586
12 Monkeypox: disease epidemiology, host immunity and clinical interventions Fok‐Moon Lum, Anthony Torres‐Ruesta, Matthew Zirui Tay et al. · Nature reviews. Immunology ReviewOpen access 5 Sep 2022 565
13 Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza Nelson L.S. Lee, Paul K.S. Chan, David S.C. Hui et al. · The Journal of Infectious Diseases Open access 10 Jul 2009 535
14 Outbreak of Nipah-virus infection among abattoir workers in Singapore Nicholas Iain Paton, Yee‐Sin Leo, Sherif R. Zaki et al. · The Lancet Oct 1999 505
15 Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study Barnaby Edward Young et al. · The Lancet Open access Aug 2020 496
16 Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries Jean Bisimwa Nachega, Olalekan Abdulrahman Uthman, Jean Anderson et al. · AIDS Open access 29 Aug 2012 494
17 An Optofluidic Nanoplasmonic Biosensor for Direct Detection of Live Viruses from Biological Media Ahmet Ali Yanik, Min Huang, Osami Kamohara et al. · Nano Letters Open access 5 Nov 2010 456
18 Hybrid metagenomic assembly enables high-resolution analysis of resistance determinants and mobile elements in human microbiomes Denis Bertrand, Jim Shaw, Manesh Kalathiyappan et al. · Nature Biotechnology 29 Jul 2019 446
19 Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients Chek Meng Poh et al. · Nature Communications Open access Jun 2020 442
20 COVID-19 in Singapore—Current Experience John E.L. Wong, Yee‐Sin Leo, Chorh Chuan Tan · JAMA 20 Feb 2020 427
21 Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang et al. · Clinical Infectious Diseases Open access 21 Aug 2021 421
22 Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients Ivan Yu Jun Seah, Danielle E. Anderson, Adrian Eng Zheng Kang et al. · Ophthalmology Open access 24 Mar 2020 412
23 Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study Wan Ni Chia et al. · The Lancet Microbe Open access 23 Mar 2021 404
24 Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma Brian McCloskey, Alimuddin I. Zumla, Giuseppe Ippolito et al. · The Lancet Open access 20 Mar 2020 402
25 A Well Infant With Coronavirus Disease 2019 With High Viral Load Kai‐Qian Kam, Chee Fu Yung, Lin Cui et al. · Clinical Infectious Diseases Open access 25 Feb 2020 399
26 Persistent Arthralgia Induced by Chikungunya Virus Infection is Associated with Interleukin-6 and Granulocyte Macrophage Colony-Stimulating Factor Angela LP Chow, Zhisheng Her, Edward K. S. Ong et al. · The Journal of Infectious Diseases Open access 14 Dec 2010 390
27 Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations Karthik Gangavarapu et al. · Nature Methods Open access 23 Feb 2023 388
28 Exportation of Monkeypox Virus From the African Continent Matthew R. Mauldin et al. · The Journal of Infectious Diseases Open access 29 Aug 2020 365
29 Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study Minggui Wang et al. · The Lancet Infectious Diseases Open access114 authors 9 Nov 2021 363
30 Age groups that sustain resurging COVID-19 epidemics in the United States Mélodie Monod et al. · Science Open access 2 Feb 2021 360
31 Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection Nina Le Bert et al. · The Journal of Experimental Medicine Open access 12 Feb 2021 347
32 Hypermethylated RASSF1A in Maternal Plasma: A Universal Fetal DNA Marker that Improves the Reliability of Noninvasive Prenatal Diagnosis K.C. Allen Chan, Chunming Ding, Ageliki Gerovassili et al. · Clinical Chemistry 27 Oct 2006 344
33 Discovery and Genomic Characterization of a 382-Nucleotide Deletion in ORF7b and ORF8 during the Early Evolution of SARS-CoV-2 Yvonne C. F. Su et al. · mBio Open access 20 Jul 2020 324
34 Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study Jinnethe Reyes et al. · The Lancet Microbe Open access 9 Feb 2023 323
35 Cross-kingdom synthetic microbiota supports tomato suppression of Fusarium wilt disease Xin Mei Zhou, Jinting Wang, Fang Liu et al. · Nature Communications Open access 22 Dec 2022 314
36 Global disparities in SARS-CoV-2 genomic surveillance Anderson Fernandes Brito et al. · Nature Communications Open access212 authors 16 Nov 2022 312
37 Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew et al. · Clinical Microbiology and Infection Open access 23 Nov 2021 306
38 IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity Lisa F. P. Ng, Lisa F. P. Ng, Angela LP Chow et al. · PLoS ONE Open access 21 Jan 2009 301
39 Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Melvin Khee‐Shing Leow, Daniel Seow‐Khee Kwek, Alan Wei‐Keong Ng et al. · Clinical Endocrinology Open access 5 Jul 2005 298
40 Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis John J.Y. Zhang, Keng Siang Lee, Li Wei Ang et al. · Clinical Infectious Diseases ReviewOpen access 11 May 2020 296
41 Connecting clusters of COVID-19: an epidemiological and serological investigation Sarah Ee Fang Yong, Danielle E. Anderson, Wycliffe Enli Wei et al. · The Lancet Infectious Diseases Open access 21 Apr 2020 296
42 Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia Steven Y. C. Tong et al. · JAMA Open access 11 Feb 2020 291
43 Global epidemiology of avian influenza A H5N1 virus infection in humans, 1997–2015: a systematic review of individual case data Shengjie Lai, Ying Qin, Benjamin John Cowling et al. · The Lancet Infectious Diseases ReviewOpen access 17 May 2016 286
44 Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) Chuen Wen Tan, Liam Pock Ho, Shirin Kalimuddin et al. · Nutrition Open access 8 Sep 2020 282
45 Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control Cheryl Yi‐Pin Lee, Raymond Tzer Pin Lin, Laurent Rénia et al. · Frontiers in Immunology Open access 24 Apr 2020 281
46 Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment Kern Rei Chng et al. · Nature Medicine Open access110 authors Jun 2020 265
47 Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 Erik Alm, Eeva Broberg, Thomas R. Connor et al. · Eurosurveillance Open access 13 Aug 2020 264
48 The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Jonathan E. Pekar et al. · Science Open access 26 Jul 2022 258
49 Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial Jenny Guek Hong Low et al. · The Lancet Infectious Diseases 27 May 2014 254
50 The Epidemiology of Hand, Foot and Mouth Disease in Asia Wee Ming Koh, Tiffany L. Bogich, Karen R. Siegel et al. · The Pediatric Infectious Disease Journal Open access 4 Jun 2016 253

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.